Skip to main content
. 2021 Jan 12;11:525933. doi: 10.3389/fneur.2020.525933

Table 1.

Results of antibody testing in retrospective cohort.

n samples analyzed MOG antibody+ AQP4 antibody+ NMDAR antibody+ Remaining seronegative
Seronegative
“NMO suspects” cohort*
146 21 8 2 115
MS controls 20 1 0 1 18
*

Previously seronegative for AQP4 antibodies. MOG = myelin oligodendrocyte glycoprotein. AQP4 = aquaporin four. NMDAR = N-Methyl-D-aspartate receptor. MS = multiple sclerosis.